Skystar Bio-Pharmaceutical Company news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

SKBI 2.60 -0.25 (-8.77%)
price chart
The major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI ...
John Gregory is the major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) 3.06 +0.04 1.32% . He lately purchased 35,000 shares in the company with the transaction value amounting to approx.
Skystar Bio-Pharmaceutical Company major shareholder John M. Gregory ...  Mideast Time
Skystar Bio-Pharmaceutical Company Announces Receipt of Nasdaq Non ...
XI'AN, CHINA, May 22, 2015 (Marketwired via COMTEX) -- Skystar Bio-Pharmaceutical Company SKBI, +2.60% a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced today that the ...
Skystar Bio-Pharmaceutical Company Stock Upgraded (SKBI)
Skystar Bio-Pharmaceutical Company, through its subsidiaries, engages in the research, development, production, marketing, and sale of veterinary healthcare and medical care products in the People's Republic of China.
Related articles »  
Skystar Bio-Pharmaceutical Company Announces Submission of Plan of ...
XI'AN, CHINA--(Marketwired - Jun 15, 2015) - Skystar Bio-Pharmaceutical Company ( NASDAQ : SKBI ) (the "Company"), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced today that ...
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)'s major shareholder ...
In a document that's submitted to the U.S. SEC, it was revealed that the major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) 3.02 -0.05 -1.63% John Gregory, an insider in focus, made purchase via broker for 38,730 shares of the ...
Skystar Bio-Pharmaceutical Company Downgraded to Hold at TheStreet (SKBI)
In other Skystar Bio-Pharmaceutical Company news, major shareholder John M. Gregory acquired 50,000 shares of the company's stock on the open market in a transaction dated Wednesday, May 6th.
Skystar Bio-Pharmaceutical Company (SKBI) Q3 2014 Results - Earnings Call ...
Greetings and welcome to the Skystar Bio-Pharmaceutical Unaudited Third Quarter Fiscal 2014 Results Conference Call. At this time, all participants are in a listen-only mode.
Related articles »  
Skystar Bio-Pharmaceutical Company Short Interest Update
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) has witnessed a drop of 37% or 33,584 shares in its short figure. The short interest diminution took it from 90,742 on May 29,2015 to 57,158 on June 15,2015.
Mid-Day Changers: Skystar Bio Pharmaceutical Company (SKBI), Blue Bird ...  WallStreet Scope
Insider Buying: Skystar Bio-Pharmaceutical Company major shareholder ...
Skystar Bio-Pharmaceutical Company logo Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) major shareholder John M. Gregory purchased 35,000 shares of the company's stock on the open market in a transaction that occurred on Thursday, April 16th ...
Update: Skystar Bio-Pharmaceutical Company Q3 Earnings - Key Developments ...
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) reported double-digit increases for both revenue and net income for Q3. Revenue increased 14.8% to $18.4 million, while net income increased 32% to $4.9 million or $0.57 per fully diluted share.
Related articles »